Skip to main content
Top
Published in: Neurocritical Care 2/2024

07-06-2023 | Status Epilepticus | Original work

Clinician-Reported Physical and Cognitive Impairments After Convulsive Status Epilepticus: Post Hoc Study of a Randomized Controlled Trial

Authors: Gwenaëlle Jacq, Benoit Crepon, Matthieu Resche-Rigon, Maleka Schenck, Thomas Geeraerts, Ferhat Meziani, Bruno Megarbane, Cendrine Chaffaut, Alain Cariou, Stephane Legriel

Published in: Neurocritical Care | Issue 2/2024

Login to get access

Abstract

Background

Clinician-reported outcome (ClinRO) measures are emerging as useful contributors to assessments of treatment benefits. The objective of this study was to collect ClinRO measures of physical and cognitive impairments after convulsive status epilepticus (CSE) requiring intensive care unit admission.

Methods

We conducted a post hoc analysis of the data from HYBERNATUS, a multicenter open-label controlled trial that randomized 270 critically ill patients with CSE requiring mechanical ventilation in 11 French intensive care units to therapeutic hypothermia (32–34 °C for 24 h) plus standard care or standard care alone. We included all patients who attended a day 90 in-person neurologist visit with measurement of the functional independence measure (FIM) score (range from 18 [total assistance] to 126 [total independence]), Mini-Mental State Examination (MMSE) score (range 0–30), and Glasgow outcome scale (GOS) score (1, death; 2, vegetative state; 3, severe disability; 4, moderate disability; and 5, mild or no disability). These three scores were compared across groups defined by several patient and CSE characteristics.

Results

Of 229 patients with GOS scores ≥ 3 on day 90 (male sex, 58.2%; median age, 56 years [47–67]), 67 (29%) attended an in-person neurologist visit. Twenty-nine (43%) patients had a previous history of epilepsy, and 16 (24%) patients had a primary brain insult. CSE was refractory in 22 (33%) patients. On day 90 after CSE onset, median FIM and MMSE scores were 121 (112–125) and 26.0 (24.0–28.8), respectively. The GOS score was 3 in 16 (33.8%) patients, 4 in 9 (13.4%) patients, and 5 in 42 (62.7%) patients. Worse GOS score values were significantly associated with worse FIM and MMSE scores.

Conclusions

In patients attending the in-person neurologist visit on day 90 after CSE onset, ClinRO measures indicated that the main impairments were cognitive. FIM and MMSE scores were associated with GOS scores. Further studies are needed to evaluate the possible impact of neuroprotective and rehabilitation strategies on disability and cognitive impairments in survivors of CSE.
Clinical trial registration NCT01359332.
Appendix
Available only for authorised users
Literature
17.
go back to reference Keith RA, Granger CV, Hamilton BB, Sherwin FS. The functional independence measure: a new tool for rehabilitation. Adv Clin Rehabil. 1987;1:6–18.PubMed Keith RA, Granger CV, Hamilton BB, Sherwin FS. The functional independence measure: a new tool for rehabilitation. Adv Clin Rehabil. 1987;1:6–18.PubMed
26.
go back to reference Herrmann EK, Hahn K, Kratzer C, von Seggern I, Zimmer C, Schielke E. Status epilepticus as a risk factor for postencephalitic parenchyma loss evaluated by ventricle brain ratio measurement on MR imaging. AJNR Am J Neuroradiol. 2006;27(6):1245–51.PubMedPubMedCentral Herrmann EK, Hahn K, Kratzer C, von Seggern I, Zimmer C, Schielke E. Status epilepticus as a risk factor for postencephalitic parenchyma loss evaluated by ventricle brain ratio measurement on MR imaging. AJNR Am J Neuroradiol. 2006;27(6):1245–51.PubMedPubMedCentral
Metadata
Title
Clinician-Reported Physical and Cognitive Impairments After Convulsive Status Epilepticus: Post Hoc Study of a Randomized Controlled Trial
Authors
Gwenaëlle Jacq
Benoit Crepon
Matthieu Resche-Rigon
Maleka Schenck
Thomas Geeraerts
Ferhat Meziani
Bruno Megarbane
Cendrine Chaffaut
Alain Cariou
Stephane Legriel
Publication date
07-06-2023
Publisher
Springer US
Published in
Neurocritical Care / Issue 2/2024
Print ISSN: 1541-6933
Electronic ISSN: 1556-0961
DOI
https://doi.org/10.1007/s12028-023-01758-6

Other articles of this Issue 2/2024

Neurocritical Care 2/2024 Go to the issue